Table 2.
Clinical data dependent on the NR2F6 status
| Characteristic | Total (n = 117) | NR2F6 positive (n = 46) | NR2F6 negative (n = 71) | p-value | |
|---|---|---|---|---|---|
| Age (average, years) | 67.5 ± 12.2 | 63.9 ± 12.0 | 68.0 ± 12.6 | n.s. | |
| FIGO I–II | 88 (75.2%) | 39 (33.3%) | 49 (41.9%) | n.s. | |
| FIGO III–IV | 27 (23.1.2%) | 5 (4.3%) | 22 (18.8%) | 0.02 | |
| BMI (average, kg/m2) | 30.1 ± 8.4 | 29.8 ± 7.5 | 30.5 ± 9.5 | n.s. | |
| Histology | Endometrioid | 104 (88.9%) | 42 (35.9%) | 62 (52.9%) | n.s. |
| Other | 12 (10.3%) | 4 (3.4%) | 8 (6.8%) | n.s. | |
| p53 status | Aberrant | 48 (41%) | 15 (12.8%) | 33 (28.2%) | n.s. |
| Wild type | 68 (58.1%) | 31 (26.5%) | 37 (31.6%) | n.s. | |
| MMR status | deficient | 71 (60.7%) | 20 (17.1%) | 51 (43.6%) | 0.003 |
| Proficient | 45 (38.5%) | 25 (21.4%) | 20 (17.1%) | n.s. | |
| Grading (G) | G1 or G2 | 93 (79.5%) | 38 (32.5%) | 55 (47%) | n.s. |
| G3 | 24 (20.5%) | 8 (6.8%) | 16 (13.7%) | n.s | |